Clinical Trial Update: Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1/2 study evaluating LM-302 in combination with toripalimab in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• LM-302
• Toripalimab (Toripalimab)

Snippet

Sponsor: LaNova Australia Pty Limited | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED